Icon

COSOPT PF (nda202667)- (EQ 2% BASE;EQ 0.5% BASE)

DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE THEA PHARMA
EQ 2% BASE;EQ 0.5% BASE
No No
Expired Expired
None None
None No
COSOPT PF is a carbonic anhydrase inhibitor with a betaadrenergic receptor blocking agent indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers. The IOP-lowering of COSOPT twice daily was slightly less than that seen with the concomitant administration of 0.5% timolol twice daily, and 2% dorzolamide three times daily.
3 0 3
Total Other Developers 1
Drugs with Suitability No
EQ 2% BASE;EQ 0.5% BASE ** ** Up - 3
NDA Sales Available Total Generic Sales Available
Yes 3
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** ****** ***** ****** ************ ******* *********** ****-***, **** **: *, ** ** **, ****, *****, ***, ************, ********** ******, **********, ********* ******, ***** (***) ***
****** ***** **** ***** **** ******* *********** ***-***, ** *****, ****** **** ****, *****, *********** ********** ****, *********, ********* ******, ***** (***) ***
****** ******* ****** *** *********** *************** *********** ** ****** ******* **********, ***********, -****** *****- *****, ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.